Loading...
Header Logo
Keywords
Last Name
Institution

Charles Birbara

Concepts (81)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
8
2015
225
1.160
Why?
Antirheumatic Agents
7
2015
112
1.090
Why?
Antibodies, Monoclonal
6
2013
659
0.500
Why?
Tumor Necrosis Factor-alpha
5
2015
488
0.480
Why?
Low Back Pain
2
2011
96
0.410
Why?
Sulfones
1
2003
22
0.320
Why?
Cyclooxygenase Inhibitors
1
2003
30
0.320
Why?
Isoenzymes
1
2003
139
0.310
Why?
Pyridines
1
2003
82
0.300
Why?
Osteoarthritis, Knee
2
2013
49
0.270
Why?
Treatment Outcome
7
2015
2484
0.240
Why?
Pain
2
2013
212
0.240
Why?
Disability Evaluation
2
2015
148
0.240
Why?
C-Reactive Protein
2
2015
170
0.200
Why?
Adult
11
2015
9277
0.200
Why?
Aged
9
2015
7250
0.190
Why?
Middle Aged
11
2015
9460
0.190
Why?
Methotrexate
3
2006
71
0.190
Why?
Severity of Illness Index
4
2015
805
0.190
Why?
Immunoconjugates
2
2006
35
0.190
Why?
Viscosupplements
1
2013
1
0.160
Why?
Methylprednisolone
1
2013
17
0.160
Why?
Hyaluronic Acid
1
2013
19
0.150
Why?
Adrenal Cortex Hormones
1
2013
48
0.150
Why?
Male
11
2015
16625
0.150
Why?
Female
11
2015
18041
0.140
Why?
Analgesics, Non-Narcotic
1
2011
26
0.140
Why?
Receptor, Nerve Growth Factor
1
2010
4
0.130
Why?
Double-Blind Method
5
2013
456
0.120
Why?
Humans
12
2015
33055
0.110
Why?
Injections, Intravenous
3
2013
142
0.100
Why?
Pneumococcal Vaccines
1
2007
15
0.100
Why?
Influenza Vaccines
1
2007
43
0.100
Why?
Managed Care Programs
1
2005
89
0.090
Why?
Cyclooxygenase 2 Inhibitors
1
2003
24
0.080
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
26
0.080
Why?
Cyclooxygenase 2
1
2003
53
0.080
Why?
Quality of Life
1
2006
427
0.070
Why?
Pain Measurement
2
2013
184
0.070
Why?
Chronic Disease
1
2003
528
0.060
Why?
Drug Therapy, Combination
3
2005
339
0.060
Why?
Injections, Subcutaneous
2
2013
51
0.060
Why?
Adolescent
2
2006
3948
0.050
Why?
Membrane Proteins
1
2003
647
0.050
Why?
Aged, 80 and over
3
2013
2693
0.050
Why?
Matrix Metalloproteinase 3
1
2013
8
0.040
Why?
Injections, Intra-Articular
1
2013
9
0.040
Why?
Ferritins
1
2013
26
0.040
Why?
Antimicrobial Cationic Peptides
1
2013
45
0.040
Why?
Interleukin-6
1
2013
233
0.040
Why?
Nerve Growth Factor
1
2011
4
0.040
Why?
Paresthesia
1
2010
2
0.030
Why?
Drug Administration Schedule
1
2011
218
0.030
Why?
Headache
1
2010
34
0.030
Why?
Respiratory Tract Infections
1
2010
54
0.030
Why?
Walking
1
2010
108
0.030
Why?
Prospective Studies
1
2013
1573
0.030
Why?
Inflammation
1
2013
647
0.030
Why?
Hemagglutination Inhibition Tests
1
2007
15
0.030
Why?
Dose-Response Relationship, Immunologic
1
2007
56
0.030
Why?
Antibody Formation
1
2007
101
0.020
Why?
Sickness Impact Profile
1
2006
30
0.020
Why?
Antibodies, Bacterial
1
2007
146
0.020
Why?
International Cooperation
1
2006
60
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
399
0.020
Why?
Infusions, Parenteral
1
2005
21
0.020
Why?
Antibodies, Viral
1
2007
213
0.020
Why?
Infection
1
2005
58
0.020
Why?
Drug Utilization Review
1
2005
52
0.020
Why?
Survival Analysis
1
2005
364
0.020
Why?
Proportional Hazards Models
1
2005
439
0.020
Why?
Matrix Metalloproteinase 1
1
2003
6
0.020
Why?
Dose-Response Relationship, Drug
1
2005
694
0.020
Why?
Enzyme Precursors
1
2003
12
0.020
Why?
Collagenases
1
2003
15
0.020
Why?
Metalloendopeptidases
1
2003
26
0.020
Why?
Multivariate Analysis
1
2005
687
0.020
Why?
Fatigue
1
2003
56
0.020
Why?
Combined Modality Therapy
1
2003
245
0.020
Why?
Follow-Up Studies
1
2005
1483
0.020
Why?
Time Factors
1
2005
2524
0.010
Why?
Birbara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_